Form 4: Trevi Therapeutics CEO Jennifer Good Reports Stock Transactions
SEC Form 4
Jennifer Good, CEO of Trevi Therapeutics, reports the exercise of stock options and subsequent sale of common stock.
Summary
- On March 21, 2025, Jennifer Good, the President & CEO of Trevi Therapeutics, exercised stock options to acquire 5,263 shares of common stock at a price of $1.43 per share.
- Simultaneously, she sold 5,263 shares of common stock at a weighted average price of $6.5789, with prices ranging from $6.55 to $6.60.
- Following these transactions, Ms. Good directly owns 213,313 shares of Trevi Therapeutics common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the trading activities of company executives. It's common for executives to exercise stock options and sell a portion of the acquired shares for personal financial management.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 05/15/2015 | Stock option grant date |
| 05/15/2016 | 25% of stock options vested |
| 05/15/2019 | Remaining 75% of stock options fully vested |
| 03/21/2025 | Exercise of stock options and sale of common stock |
| 03/25/2025 | Date of signature for the Form 4 filing |
| 05/14/2025 | Expiration date of the stock options |
Keywords
Trevi Therapeutics, Jennifer Good, stock options, common stock, Form 4, insider trading, TRVI
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.